My quick thoughts: -clinically - it works pretty
Post# of 148173
-clinically - it works pretty darn well, saves lives, reduces hospital stays, increases likelihood of leaving hospital alive
-statistically - reduces hospital stay duration by SIX days (huge as lockdowns were enacted partially to buy hospitals time and capacity)
-my litmus test - forward progress? Absolutely
-EUA - fully justified based on criteria for EUA and Woodcock (an actual human being with feelings and a common sense approach) being current head
-tbd - tweaking trial to achieve whatever it is they feel they need to achieve to get full approval
There is nothing here that indicates to me anything other than LL works better than SOC alone, way better than placebo, and something I would fight tooth and nail for to give to a family member as soon as effin possible if they were hospitalized. If I’m willing to do that, for me, that means there is something right going on here...they always say to invest in what you know and invest in a good product. Good nuff for me...
Monday reaction meaningless. $2 or $6 doesn’t change any of the above nor the path to achieve the endpoints we know are inevitable. Then uplist. Then HIV. Then then then...
long term picture is still being pixelated one day at a time, weak hands have their nose pressed against the painting. Strong hands are viewing from afar.
Amazon fell 95% after the dotcom bust. Just sayin... I ain’t going nowhere.
My go-to clip:
https://youtu.be/kIbEj1CIpuU